Janney Montgomery Scott LLC Grows Stake in BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Janney Montgomery Scott LLC grew its position in BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) by 13.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,150 shares of the company’s stock after purchasing an additional 2,000 shares during the quarter. Janney Montgomery Scott LLC’s holdings in BlackRock Capital Allocation Term Trust were worth $260,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Penserra Capital Management LLC purchased a new stake in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at $15,901,000. Mathes Company Inc. grew its holdings in shares of BlackRock Capital Allocation Term Trust by 6.0% during the third quarter. Mathes Company Inc. now owns 96,500 shares of the company’s stock valued at $1,587,000 after buying an additional 5,500 shares during the last quarter. Oppenheimer & Co. Inc. grew its holdings in shares of BlackRock Capital Allocation Term Trust by 10.9% during the third quarter. Oppenheimer & Co. Inc. now owns 57,248 shares of the company’s stock valued at $942,000 after buying an additional 5,618 shares during the last quarter. Fountainhead AM LLC grew its holdings in shares of BlackRock Capital Allocation Term Trust by 2.1% during the third quarter. Fountainhead AM LLC now owns 53,570 shares of the company’s stock valued at $881,000 after buying an additional 1,095 shares during the last quarter. Finally, Claro Advisors LLC grew its holdings in shares of BlackRock Capital Allocation Term Trust by 101.3% during the third quarter. Claro Advisors LLC now owns 31,734 shares of the company’s stock valued at $522,000 after buying an additional 15,969 shares during the last quarter. 36.12% of the stock is owned by hedge funds and other institutional investors.

BlackRock Capital Allocation Term Trust Price Performance

Shares of BCAT opened at $15.71 on Thursday. BlackRock Capital Allocation Term Trust has a 1-year low of $15.00 and a 1-year high of $17.18. The company’s fifty day moving average price is $15.62 and its 200-day moving average price is $16.03.

BlackRock Capital Allocation Term Trust Increases Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, February 28th. Stockholders of record on Friday, February 14th will be issued a dividend of $0.2882 per share. The ex-dividend date is Friday, February 14th. This is a positive change from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. This represents a $3.46 dividend on an annualized basis and a dividend yield of 22.02%.

BlackRock Capital Allocation Term Trust Company Profile

(Free Report)

Featured Stories

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.